Fatty Pancreas is no longer considered a harmless finding on medical scans. A global Expert Consensus has now recognized it as a disease.
A Rare Brain Disorder linked to Measles is now under the spotlight as a Hyderabad-based institute launches a new Research Study.
Poviztra Approval has marked a major step for fatty liver treatment in India. Emcure Pharmaceuticals has received CDSCO approval to market Poviztra for eligible adults with MASH.
India has cleared Fasenra expansion as AstraZeneca targets severe asthma patients with a wider treatment option.
Tatva Chintan's Q1 Surprise pushed the company's shares up by 18% on strong first-quarter earnings. Tatva Chintan gained 18.13% to Rs 1,687 after reporting sharp growth in profit and revenue.
India has taken a major step in fighting Dengue Vaccine after the country's first vaccine received approval. The approval marks a key moment for public health.
COVID Alert has returned to the spotlight after fresh Maharashtra COVID cases were reported nearly three years after infections remained low.
People with type 2 diabetes face a higher severe dengue risk, according to a new study. Researchers found the condition can increase the chances of dangerous dengue complications.
The US Cancer Market has moved a step closer for Alembic Pharma and Natco Pharma after the companies secured a key regulatory milestone.
Novo Nordisk’s Wegovy gains CDSCO approval for MASH in India, marking a key GLP-1 expansion into liver disease, strengthening its role in metabolic disorder treatment.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")